Sunday, June 1, 2025

Latest

Curing The Banana Panama Disease – The Daily Dive feat Colin Bletsky of MustGrow Biologics

Kickstarting our short holiday week for the Daily Dive is that of Colin Bletsky, COO of MustGrow Biologics (CSE: MGRO). Colin sits down with our host Cassandra Leah to discuss food security, the food chain, the use of synthetic chemicals within farming, and the natural bio-solutions that MustGrow is bringing to market.

MustGrow Biologics is an agriculture bio-tech firm that is working to develop natural biological solutions to replace synthetic chemicals used within farming. The firm is currently focused on developing several mustard-derived biopesticides to ultimately replace these synthetic chemicals. Currently, the firm is largely focused on diseases such as Panama Disease, clubroot, Fusarium, and more that don’t currently have sufficient solutions in the marketplace.

View the full interview below.


FULL DISCLOSURE: MustGrow Biologics Corp is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover MustGrow Biologics Corp on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Leave a Reply

Video Articles

Silver47 x Summa Silver: Creating An Explorer With A Billion Ounce Goal

Alamos Gold Q1 Earnings: The Inside Scoop

Cerrado Gold Q4 Earnings: The Turnaround is Working

Recommended

Silver47 x Summa Silver: Creating An Explorer With A Billion Ounce Goal

Canadian Copper: The $172M Combined Strategy PEA

Related News

MustGrow Biologics To Collaborate With Univar Solutions On Field Trials

MustGrow Biologics (CSE: MGRO) is progressing with field trials for its TerraMG product. The company...

Thursday, April 29, 2021, 08:02:05 AM

MustGrow Biologics Sees Continued Positive Results From Field Trials For Banana Panama Disease

MustGrow Biologics (CSE: MGRO) has finally seen the results of its initial field trial program...

Wednesday, November 10, 2021, 08:01:52 AM

MustGrow Secures Patent For Mustard-Based Sprout Suppressant

MustGrow Biologics (CSE: MGRO) is pushing forward with its focus on natural biopesticides, this morning...

Monday, November 23, 2020, 07:27:00 AM

MustGrow Biologics Reports Positive Trial Results In Colombia

MustGrow Biologics (CSE: MGRO) this morning released further results from ongoing field trials being conducted...

Monday, July 12, 2021, 07:33:27 AM

MustGrow Acquires NexusBioAg For $1.66 Million In Cash, Future Earn-Out Payments

MustGrow Biologics (TSXV: MGRO) has completed the previously announced acquisition of NexusBioAg from Univar Solutions...

Thursday, January 2, 2025, 08:29:18 AM